Your browser doesn't support javascript.
loading
Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male rats.
Purves-Tyson, Tertia D; Boerrigter, Danny; Allen, Katherine; Zavitsanou, Katerina; Karl, Tim; Djunaidi, Vanezha; Double, Kay L; Desai, Reena; Handelsman, David J; Weickert, Cynthia Shannon.
Afiliação
  • Purves-Tyson TD; Schizophrenia Research Institute, Sydney, Australia; Schizophrenia Research Laboratory, Neuroscience Research Australia, Barker Street, Sydney, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Australia. Electronic address: t.purves-tyson@neura.edu.au.
  • Boerrigter D; Schizophrenia Research Laboratory, Neuroscience Research Australia, Barker Street, Sydney, Australia.
  • Allen K; Schizophrenia Research Institute, Sydney, Australia; Schizophrenia Research Laboratory, Neuroscience Research Australia, Barker Street, Sydney, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Zavitsanou K; Schizophrenia Research Institute, Sydney, Australia; Schizophrenia Research Laboratory, Neuroscience Research Australia, Barker Street, Sydney, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Karl T; Neuroscience Research Australia, Barker Street, Sydney, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Australia.
  • Djunaidi V; Schizophrenia Research Institute, Sydney, Australia; Schizophrenia Research Laboratory, Neuroscience Research Australia, Barker Street, Sydney, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Australia.
  • Double KL; Discipline of Biomedical Science, School of Medical Sciences, Sydney Medical School, University of Sydney, Australia.
  • Desai R; ANZAC Research Institute, University of Sydney, Concord Hospital, Australia.
  • Handelsman DJ; ANZAC Research Institute, University of Sydney, Concord Hospital, Australia.
  • Weickert CS; Schizophrenia Research Institute, Sydney, Australia; Schizophrenia Research Laboratory, Neuroscience Research Australia, Barker Street, Sydney, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.
Horm Behav ; 70: 73-84, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25747465
ABSTRACT
Although sex steroids are known to modulate brain dopamine, it is still unclear how testosterone modifies locomotor behaviour controlled, at least in part, by striatal dopamine in adolescent males. Our previous work suggests that increasing testosterone during adolescence may bias midbrain neurons to synthesise more dopamine. We hypothesised that baseline and amphetamine-induced locomotion would differ in adult males depending on testosterone exposure during adolescence. We hypothesised that concomitant stimulation of estrogen receptor signaling, through a selective estrogen receptor modulator (SERM), raloxifene, can counter testosterone effects on locomotion. Male Sprague-Dawley rats at postnatal day 45 were gonadectomised (G) or sham-operated (S) prior to the typical adolescent testosterone increase. Gonadectomised rats were either given testosterone replacement (T) or blank implants (B) for six weeks and sham-operated (i.e. intact or endogenous testosterone group) were given blank implants. Subgroups of sham-operated, gonadectomised and gonadectomised/testosterone-replaced rats were treated with raloxifene (R, 5mg/kg) or vehicle (V), daily for the final four weeks. There were six groups (SBV, GBV, GTV, SBR, GBR, GTR). Saline and amphetamine-induced (1.25mg/kg) locomotion in the open field was measured at PND85. Gonadectomy increased amphetamine-induced locomotion compared to rats with endogenous or with exogenous testosterone. Raloxifene increased amphetamine-induced locomotion in rats with either endogenous or exogenous testosterone. Amphetamine-induced locomotion was negatively correlated with testosterone and this relationship was abolished by raloxifene. Lack of testosterone during adolescence potentiates and testosterone exposure during adolescence attenuates amphetamine-induced locomotion. Treatment with raloxifene appears to potentiate amphetamine-induced locomotion and to have an opposite effect to that of testosterone in male rats.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testosterona / Cloridrato de Raloxifeno / Moduladores Seletivos de Receptor Estrogênico / Anfetamina / Estimulantes do Sistema Nervoso Central / Atividade Motora Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testosterona / Cloridrato de Raloxifeno / Moduladores Seletivos de Receptor Estrogênico / Anfetamina / Estimulantes do Sistema Nervoso Central / Atividade Motora Idioma: En Ano de publicação: 2015 Tipo de documento: Article